Scimago Institutions Rankings
menu
| Title | Type |  SJR |
H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 7.292 Q1 | 289 | 170 | 654 | 7838 | 5186 | 325 | 15.15 | 46.11 |  |
| 2 | Pharmacology and Therapeutics | journal | 4.252 Q1 | 180 | 89 | 307 | 15071 | 2834 | 302 | 9.70 | 169.34 | |
| 3 | Neuropsychopharmacology | journal | 3.385 Q1 | 204 | 321 | 789 | 19801 | 4903 | 742 | 6.45 | 61.69 | |
| 4 | Natural Product Reports | journal | 2.918 Q1 | 157 | 58 | 171 | 8919 | 1025 | 160 | 5.97 | 153.78 | |
| 5 | Particle and Fibre Toxicology | journal | 2.227 Q1 | 83 | 20 | 38 | 718 | 300 | 38 | 5.85 | 35.90 | |
| 6 | Critical Reviews in Toxicology | journal | 2.095 Q1 | 98 | 45 | 95 | 5208 | 621 | 88 | 6.91 | 115.73 | |
| 7 | Journal of Antimicrobial Chemotherapy | journal | 2.076 Q1 | 172 | 503 | 1273 | 11903 | 4870 | 1030 | 4.69 | 23.66 | |
| 8 | Environmental Pollution | journal | 1.922 Q1 | 194 | 522 | 1130 | 21963 | 3911 | 1111 | 3.28 | 42.07 | |
| 9 | Pharmacogenomics Journal | journal | 1.911 Q1 | 78 | 37 | 137 | 1597 | 804 | 131 | 5.61 | 43.16 | |
| 10 | International Journal of Neuropsychopharmacology | journal | 1.843 Q1 | 93 | 98 | 236 | 5162 | 947 | 206 | 4.16 | 52.67 | |
| 11 | Neuropharmacology | journal | 1.797 Q1 | 150 | 241 | 743 | 13687 | 2555 | 737 | 3.30 | 56.79 | |
| 12 | Toxicological Sciences | journal | 1.752 Q1 | 164 | 198 | 995 | 8909 | 4093 | 942 | 4.42 | 44.99 | |
| 13 | Antiviral Therapy | journal | 1.698 Q1 | 78 | 105 | 394 | 3349 | 1352 | 379 | 3.36 | 31.90 | |
| 14 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.628 Q1 | 81 | 56 | 208 | 1838 | 500 | 197 | 2.26 | 32.82 | |
| 15 | Tetrahedron | journal | 1.605 Q1 | 209 | 1219 | 3763 | 60373 | 11247 | 3700 | 2.93 | 49.53 | |
| 16 | Expert Opinion on Therapeutic Targets | journal | 1.533 Q1 | 78 | 111 | 302 | 11329 | 994 | 278 | 3.86 | 102.06 | |
| 17 | Clinical Pharmacokinetics | journal | 1.480 Q1 | 150 | 58 | 225 | 3666 | 1225 | 213 | 5.05 | 63.21 | |
| 18 | Journal of Nanobiotechnology | journal | 1.400 Q1 | 57 | 11 | 31 | 343 | 132 | 29 | 4.00 | 31.18 | |
| 19 | Current Opinion in Drug Discovery and Development | journal | 1.394 Q1 | 75 | 74 | 205 | 4597 | 766 | 185 | 4.38 | 62.12 | |
| 20 | Tetrahedron Letters | journal | 1.346 Q1 | 159 | 1682 | 5771 | 53569 | 14807 | 5692 | 2.55 | 31.85 | |
| 21 | Human Genomics | journal | 1.272 Q1 | 49 | 10 | 56 | 137 | 137 | 43 | 2.54 | 13.70 | |
| 22 | PharmacoEconomics | journal | 1.257 Q1 | 91 | 75 | 307 | 3288 | 798 | 257 | 2.69 | 43.84 | |
| 23 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 94 | 154 | 451 | 10572 | 1604 | 418 | 3.94 | 68.65 | |
| 24 | Drug Safety | journal | 1.221 Q1 | 115 | 89 | 279 | 3789 | 986 | 242 | 3.74 | 42.57 | |
| 25 | Bioorganic and Medicinal Chemistry | journal | 1.206 Q1 | 142 | 888 | 2150 | 32653 | 6348 | 2129 | 2.97 | 36.77 | |
| 26 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.204 Q1 | 70 | 18 | 53 | 3139 | 217 | 50 | 3.65 | 174.39 | |
| 27 | Expert Opinion on Biological Therapy | journal | 1.198 Q1 | 75 | 126 | 406 | 10965 | 1252 | 403 | 3.52 | 87.02 | |
| 28 | Bioorganic and Medicinal Chemistry Letters | journal | 1.140 Q1 | 133 | 1249 | 3552 | 31459 | 9180 | 3509 | 2.57 | 25.19 | |
| 29 | Current Opinion in Investigational Drugs | journal | 1.135 Q1 | 71 | 126 | 375 | 8936 | 1036 | 341 | 3.54 | 70.92 | |
| 30 | Mutagenesis | journal | 1.133 Q1 | 82 | 47 | 161 | 2820 | 447 | 152 | 2.97 | 60.00 | |
| 31 | BioDrugs | journal | 1.121 Q1 | 60 | 38 | 110 | 3093 | 338 | 106 | 2.80 | 81.39 | |
| 32 | Addictive Behaviors | journal | 1.118 Q1 | 114 | 171 | 694 | 5592 | 1511 | 691 | 2.02 | 32.70 | |
| 33 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 1.100 Q1 | 62 | 0 | 67 | 0 | 172 | 63 | 0.00 | 0.00 | |
| 34 | British Journal of Clinical Pharmacology | journal | 1.073 Q2 | 131 | 259 | 655 | 6483 | 1768 | 523 | 3.36 | 25.03 | |
| 35 | Current Opinion in Molecular Therapeutics | journal | 1.069 Q1 | 60 | 58 | 229 | 3979 | 541 | 201 | 2.99 | 68.60 | |
| 36 | Drug Metabolism and Pharmacokinetics | journal | 1.045 Q1 | 58 | 57 | 178 | 1592 | 552 | 174 | 2.79 | 27.93 | |
| 37 | BMC Chemical Biology | journal | 1.042 Q1 | 19 | 3 | 8 | 101 | 22 | 8 | 3.00 | 33.67 | |
| 38 | Expert Review of Vaccines | journal | 1.038 Q1 | 75 | 138 | 253 | 10660 | 649 | 227 | 2.95 | 77.25 | |
| 39 | Nanotoxicology | journal | 1.034 Q1 | 72 | 25 | 26 | 1137 | 92 | 25 | 3.68 | 45.48 | |
| 40 | Inhalation Toxicology | journal | 1.027 Q1 | 77 | 105 | 312 | 4035 | 701 | 294 | 2.40 | 38.43 | |
| 41 | Alcohol and Alcoholism | journal | 1.020 Q1 | 89 | 116 | 301 | 4114 | 699 | 284 | 2.26 | 35.47 | |
| 42 | Journal of Drug Targeting | journal | 1.008 Q1 | 80 | 82 | 221 | 3038 | 543 | 204 | 2.78 | 37.05 | |
| 43 | Pharmacogenomics | journal | 0.988 Q2 | 83 | 182 | 356 | 9640 | 1098 | 313 | 3.65 | 52.97 | |
| 44 | Expert Opinion on Emerging Drugs | journal | 0.986 Q2 | 43 | 31 | 131 | 3751 | 352 | 131 | 2.81 | 121.00 | |
| 45 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.952 Q2 | 72 | 124 | 187 | 10962 | 691 | 181 | 3.49 | 88.40 | |
| 46 | Expert Opinion on Drug Delivery | journal | 0.942 Q1 | 88 | 87 | 189 | 8707 | 547 | 174 | 3.37 | 100.08 | |
| 47 | Toxicon | journal | 0.898 Q2 | 116 | 290 | 690 | 10135 | 1817 | 668 | 2.65 | 34.95 | |
| 48 | Clinical and Experimental Pharmacology and Physiology | journal | 0.886 Q2 | 95 | 223 | 557 | 8646 | 1261 | 543 | 2.51 | 38.77 | |
| 49 | Journal of Toxicology and Environmental Health - Part A | journal | 0.831 Q2 | 80 | 158 | 496 | 6127 | 904 | 488 | 1.72 | 38.78 | |
| 50 | Food Additives and Contaminants | journal | 0.782 Q2 | 90 | 1 | 487 | 0 | 1297 | 475 | 2.17 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2020. Data Source: Scopus®
Download data